The methods used to achieve blastomere cell cycle synchronization in embryos used as nuclear donors during embryo reconstruction have been largely unsuccessful. The aim of this study was to determine the reliability of 6-dimethylaminopurine 
Introduction
In mammals, early embryonic processes are characterized by asynchronous cleavage which increases progressively among blastomeres throughout preimplantation development. Asynchronous cleavage appears to play a role in determining the position of blastomeres within the embryo and, in doing so, determines their fate to become inner cell mass (ICM) or trophectoderm (Sutherland et al, 1990) . Furthermore, blastomere asynchrony is also believed to cause inconsistent nucleocytoplasmic interactions in embryos reconstructed by nuclear transplantation (NT) . The negative effects of the absence of cell cycle stage synchrony between nuclear donor and recipient cytoplasm have been shown to reduce the success of NT procedure in mammals (Smith et al, 1988 (Smith et al, , 1990 Campbell et al, 1994; Otaegui et al, 1994; Stice et al, 1994) .
The presence of a high concentration of maturation promoting factor (MPF) in host oocytes enucleated at metaphase is believed to lead to premature chromosome condensation (PCC) of interphase donor nuclei immediately after fusion (Czolowska et al, 1984; Szöüösi et al, 1986; Collas and Robl, 1991; Collas et al, 1992a) . Treatments (Guerrier and Dorée, 1975; Dorée et al, 1983) and vertebrate oocyte maturation (Rime et ai., 1989) . It was also successfully used to arrest cleavage in four-cell mouse embryos, enabling synchronized entry to the fourth cell cycle (Samaké and Smith, 1996a (Parrish et al, 1986 (Fig. 1) . Time from release from 6-DMAP arrest (h) (Fig. 2) . Although no quantitative assessment was performed on the fixed embryos, an apparent increase in the size of interphase nuclei was observed in all 6-DMAP-treated embryos compared with controls (Fig. 3 ). Statistical analysis was not possible for the Hi kinase assay; however, there was a noticeable variation in the activity of this kinase. Although absent at the end of treatment, release from 6-DMAP led to an increase in the activity of histone HI kinase by 3 h, after which it decreased progressively, with complete disappearance by 5 h (Fig. 4a, b) . The timing and synchrony of entry into S-phase were assessed by removing embryos from 6-DMAP and assaying for BrdU incorporation at 2 h intervals for the following 10 h (Fig. 5) . At 4 h, reaching a maximum of 39% by 6 h, and then decreased to 28% by 10 h after removal of 6-DMAP (P<0.05). Since BrdU incorporation oscillated during the same period in control embryos, it is unknown whether 6-DMAP treatment had any effect on the synchrony of re-entry into the following S-phase. 
Toxicity
The toxicity of 6-DMAP on embryo development in vitro was assessed by exposing 180 eight-cell treated embryos for 12 h to 0-5 mmol 1~1 of the agent, then washing and culturing them in agent-free MB2 medium for a further 6 days (Fig. 6) In this study, a mimimum dose of 3 mmol 1~1 was required for 6-DMAP to successfully and reversibly arrest eight-cell bovine embryos at interphase; a similar dose was required for this agent to arrest four-cell mouse embryos at interphase (Samaké and Smith, 1996a) . However, a lower concentration (2 mmol) has been shown to prevent germinal vesicle break¬ down (GVBD) of mouse (Rime et al, 1989) and bovine oocytes (Fulka et al, 1991) . By preventing the normal phosphorylation of proteins, 6-DMAP interferes with the activity of MPF, and consequently prevents cell division (Néant et al, 1988a (Néant et al, , 1989 Rime et al, 1989) . MPF (Néant et al, 1988b (Néant et al, , 1994 , echinoderms (Néant et al, 1989; Dufresne et al, 1991) and mice (Rime et al, 1989; Szöllösi et al, 1991; Samaké and Smith, 1996a (Samaké and Smith, 1996a) and in bovine embryos in the current study, DNA synthesis was observed during and at the end of 6-DMAP treatment.
The toxicity of this agent to both mouse and bovine embryo viability may have been related to ploidy defects caused by continuous DNA synthesis after long periods of exposure to 6-DMAP. Alternatively, the observed lower cell numbers may have resulted from the 12 h arrest present in treated but not in control groups. Experiments in which these 6-DMAP-treated bovine blastocysts will be transferred to synchronized recipi¬ ents will help to assess the potential for long term toxicity on embryo viability.
The importance of synchrony between the donor and recipient cell cycle stages in embryo reconstitution studies by nuclear transfer has been well established in several species (Smith et al, 1988 (Smith et al, , 1990 Collas et al, 1992a, b; Barnes et al, 1993; Campbell et al, 1993 Campbell et al, , 1994 Cheong et al, 1993; Otaegui et al, 1994; Stice et al, 1994 
